New educational materials help patients talk to their physicians about sensitive subjects via a Patient Point joint venture of UroMed and Cure Medical to offer valuable incontinence and catheterization information in urology exam rooms. […]
mobileWOMEN.org magazine will be spotlighting the stories of UroMed’s female Hometown Heroes as an inspirational program for their readers. mobileWOMEN.org is an online magazine for women who use wheelchairs. […]
UroMed, a leading urological medical supply company, is now a preferred provider of Cure Twist™, a discreet catheter for women. UroMed is one of the nation's top providers of disposable catheters for men, women and children. […]
Biogen Idec announced that a phase III study of peginterferon beta-1a, injected under the skin either every two or four weeks, reduced the relapse rate significantly more than placebo in a study of 1500 people with relapsing MS, reaching the primary goal of the study. Peginterferon is a new formulation of the interferon beta-1a molecule which enables it to m […]
Researchers at the universities of Edinburgh and Cambridge, and at Stanford, have reported separate studies making inroads to understanding factors that stimulate the repair of myelin, the nerve insulation that is a target of multiple sclerosis. These important laboratory discoveries, supported in part by the National MS Society, are still in early stages an […]
A new study of 496 people newly diagnosed with MS found that the risk of developing MS was 47% higher in African American women, compared with Caucasian American men or women. It also found that the risk was 50% lower in Hispanic/Latino Americans, and 80% lower in Asian Americans. […]
Among 618 people at high risk of developing MS, significantly fewer people taking oral Aubagio® (teriflunomide, Genzyme, a Sanofi company) for two years had developed clinically definite MS than those taking placebo, Genzyme announced in a press release dated April 25, 2013. […]
Results that led to larger-scale clinical trials of daclizumab high-yield process (DAC HYP, Biogen Idec and Abbott Pharmaceuticals) have been published. The phase II SELECT trial found that this monoclonal antibody, taken by injection under the skin every four weeks, significantly reduced the average annual relapse rate and the risk of progression in a study […]
In April 2007, Amanda left a prom after-party with a friend who had been drinking. On the way home, the driver crashed into a ditch. Amanda’s spinal cord was injured, and she was paralyzed from the neck down. She was hospitalized for five months and went through a grueling regimen of physical therapy each day. […]
Michelle Stilwell one of three B.C. MLAs with a physical disability In much the way she views her wheelchair racing career – she is an athlete with a disability, not a disabled athlete – Michelle Stilwell isn’t overly interested in framing her new job as a politician by the fact she uses a chair. The […]
NEW YORK, May 16, 2013 /PRNewswire-USNewswire/ — United Spinal Association and The Buoniconti Fund today announced their plans to create a coordinated national network of peer support groups called the “Spinal Network” that will set higher standards in assisting people living with spinal cord injuries and disorders (SCI/D). The goal of the Spinal Network is […]
The Buoniconti Fund and National Spinal Cord Injury Association (NSCIA), intend to jointly implement a coordinated national network of local support groups called the Spinal Network. Together, the Spinal Network will establish consistent standards for local groups wishing to provide support for the people living with Spinal Cord Injury and Disorders (SCI/D), […]
The possibility of using a patient’s skin to generate healthy new heart, liver or nerve cells has moved a step closer after a breakthrough by US scientists. Using the cloning technique which produced Dolly the Sheep in 1996, researchers were able for the first time to turn human skin cells into “embryonic” stem cells, which […]